Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse
Open accessThe DOI matches its OpenAlex record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: Despite animal studies having shown a generalisation of the bupropion cue to cocaine, this drug has been used in cocaine abuse with mixed results. We here aimed at describing two cases which contradict current knowledge. CASE REPORTS: We describe two cases of former cocaine abusers who reported a cocaine-like sensation upon taking bupropion. Bupropion improved patients' depression without any increase in cocaine craving. One of the patients increased without doctor consultation his dose on an as needed basis. CONCLUSIONS: The issue of bupropion cue generalisation to cocaine needs further elucidation. People with past cocaine addiction need to be informed on the potential of bupropion to elicit cocaine-like cues and be invited to adhere to medical prescription, because bupropion has been associated with fatalities in some cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the dopaminergic, stimulant-like, bupropion activities (Vento et al., 2013) may be associated with its possible recreational value.”
From Is There a Potential of Misuse for Venlafaxine and Bupropion? (2018) · cites this paper as Vento et al., 2013
In the citing paper
“Bupropion is a cathinone derivative (Lewin et al., 2014); similar to remaining molecules of this class, one could argue that its diversion potential and reinforcement of misuse may be related to its dopaminergic and noradrenergic effects (Vento et al., 2013).”
From Is There a Potential of Misuse for Venlafaxine and Bupropion? (2018) · cites this paper as Vento et al., 2013
In the citing paper
“Most related literature papers, so far, were based on small case series/single case studies (Quaglio et al., 2008; Vento et al., 2013).”
From Is There a Potential of Misuse for Venlafaxine and Bupropion? (2018) · cites this paper as Vento et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“He was poorly motivated, anhedonic, with suicidal ideation, and suffering from sleep disturbances, scoring 30 on the Hamilton Rating Scale for Depression (Ham-D) [15].”
MethodCocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-06.2006 · Cited by 1,164 · cited 1×
“cocaine-experienced individuals [1].”
Stahl, S. M., Pradko, J., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0403 · Cited by 495
Ritz, M. C., Cone, E. J., & Kuhar, M. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90132-b · Cited by 465
Kleven, M. S., Anthony, E. W., & Woolverton, W. L. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12606-2 · Cited by 177
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients
Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01198-6 · Cited by 168
Rohsenow, D. J., Martin, R. A., Eaton, C. A., & Monti, P. M. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.641 · Cited by 116
The discriminative stimulus effects of cocaine in pigeons.
Johanson, C. E., & Barrett, J. E. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39359-6 · Cited by 84
Wei, Y., Williams, J. M., Dipace, C., Sung, U., Javitch, J. A., Galli, A., & Saunders, C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026351 · Cited by 74
Stimulus properties of antidepressants in the rat
Jones, C. N., Howard, J. L., & McBennett, S. T. (1980) · Psychopharmacology · doi:10.1007/bf00431964 · Cited by 71
Cited by
Legal highs: staying on top of the flood of novel psychoactive substances
Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314559539 · Cited by 159
New/emerging psychoactive substances and associated psychopathological consequences
Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine · doi:10.1017/s0033291719001727 · Cited by 119
Self-citationAbuse and misuse of antidepressants
Sullivan, M., & Evans, E. (2014) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s37917 · Cited by 91
Schifano, F., Chiappini, S., Corkery, J., & Guirguis, A. (2018) · Brain Sciences · doi:10.3390/brainsci8040073 · Cited by 93
Intended and unintended use of cathinone mixtures
Guirguis, A., Corkery, J. M., Stair, J. L., Kirton, S. B., Zloh, M., & Schifano, F. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2598 · Cited by 58
NPS: Medical Consequences Associated with Their Intake
Schifano, F., Orsolini, L., Papanti, D., & Corkery, J. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_15 · Cited by 66
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis
Anderson, L., Bell, H., Gilbert, M. K., Davidson, J. E., Winter, C., Barratt, M. J., Win, B., Painter, J. L., Menone, C. M., Sayegh, J., et al. (2017) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.6174 · Cited by 57
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review
Schifano, F., Chiappini, S., Miuli, A., Corkery, J., Scherbaum, N., Napoletano, F., Arillotta, D., Zangani, C., Catalani, V., Vento, A. E., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113638 · Cited by 58
Is There a Potential of Misuse for Venlafaxine and Bupropion?
Schifano, F., & Chiappini, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00239 · Cited by 38
Self-citationQuetiapine Abuse Fourteen Years Later: Where Are We Now? A Systematic Review
Vento, A. E., Kotzalidis, G. D., Cacciotti, M., Papanti, G. D., Orsolini, L., Rapinesi, C., Savoja, V., Calabrò, G., CASALE, A. D., Piacentino, D., et al. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1668013 · Cited by 36
The e-psychonaut drugs’ psychopharmacology
Schifano, F., Chiappini, S., Corkery, J., Scherbaum, N., & Guirguis, A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.02.008 · Cited by 34
Fine, J. A., Lackner, R. M., Samudrala, R., & Chopra, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-49515-0 · Cited by 27
A Concept Analysis of Substance Misuse to Inform Contemporary Terminology
Mahmoud, K. F., Finnell, D. S., Savage, C. L., Puskar, K. R., & Mitchell, A. M. (2017) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2017.06.004 · Cited by 29
Francesconi, G., Orsolini, L., Papanti, D., Corkery, J. M., & Schifano, F. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2476 · Cited by 22
Lewis, J., Sutter, M. E., Albertson, T. E., Owen, K. P., & Ford, J. B. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.969372 · Cited by 22
Naglich, A. C., Brown, E. S., & Adinoff, B. H. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1545023 · Cited by 12
New psychoactive substances: Issues and challenges
Rao, R., Patil, V. B., & Tewari, A. (2016) · Journal of Mental Health and Human Behaviour · doi:10.4103/0971-8990.193427 · Cited by 9
Synthetic Cathinones—Prevalence and Motivations for Use
Corkery, J., Guirguis, A., Papanti, D., Orsolini, L., & Schifano, F. (2018) · Current topics in neurotoxicity · doi:10.1007/978-3-319-78707-7_9 · Cited by 14
Stimulant use in patients presenting with psychocutaneous disorders
Richey, P. M., Laageide, L. G., & Swick, B. L. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.04.033 · Cited by 6
Richey, P. M., Chapin, R. W., & Avram, M. M. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.10.040 · Cited by 6
Possible Addiction Transference From Cocaine Insufflation to Oral Bupropion in Bipolar Patient
da Costa, C. B. F., de Araújo, A. J., Brasil, M. A. A., & Cruz, M. S. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000098 · Cited by 6
Barman, R., Kumar, S., Pagadala, B., & Detweiler, M. B. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000729 · Cited by 6
Aikoye, S., Basiru, T., Nwoye, I., Adereti, I., Asuquo, S. E., Ezeokoli, A., Hardy, J., & Umudi, O. (2023) · Cureus · doi:10.7759/cureus.36189 · Cited by 8
Intravenöser Missbrauch von Bupropion
Behler, N., Lehmann, A., Malchow, B., & Palm, U. (2016) · Der Nervenarzt · doi:10.1007/s00115-016-0200-3 · Cited by 1
Злоупотребление антидепрессантами: причины и возможные последствия
Кудряшов, Н. В., Королев, А. О., Касабов, К. А., Калинина, Т. С., Миронов, С. Е., & Воронина, Т. А. (2019) · Экспериментальная и клиническая фармакология · doi:10.30906/0869-2092-2019-82-3-28-35 · Cited by 2
I Encontro Acadêmico de Neurologia, Neurocirurgia e Neurociências
Gerais, U. F. D. M. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i3.1198
Metadata
- Authors
- Vento
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2013-01-01
- Volume
- 49
- Issue
- 4
- Pages
- 402-5
- OpenAlex
- W2167752793
- Cited by
- 26
- References
- 24
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 4 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 3
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- green
- uhra.herts.ac.uk
- Locations
- PubMed (publishedVersion)
- University of Hertfordshire Research Archive (University of Hertfordshire) (acceptedVersion)
- University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- bupropion, cocaine craving, depression treatment, self-medication
- MeSH terms
- Adult, Humans, Male, Middle Aged, Bupropion, Dopamine Uptake Inhibitors, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.